Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksC&C Group Regulatory News (CCR)

Share Price Information for C&C Group (CCR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 166.20
Bid: 166.20
Ask: 167.00
Change: 1.40 (0.85%)
Spread: 0.80 (0.481%)
Open: 163.20
High: 166.60
Low: 162.60
Prev. Close: 164.80
CCR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Statement re Appointment of Interim Group Chief Financial Officer

1 Aug 2017 07:00

Appointment of Interim Group Chief Financial Officer

CCR.I CCR.L

Dublin, London | 01 August 2017: C&C Group plc (“C&C” or the “Group”), a manufacturer, marketer and distributor of branded cider, beer, wine and soft drinks announces the appointment of Mr. Jonathan Solesbury as Interim Group Chief Financial Officer for a period of 12 months, effective today.

A former SABMiller plc Director of Group Finance, Jonathan held a number of senior roles during his 22 year tenure with the global drinks company. Initially responsible for evaluating and executing new business opportunities across Central Europe and Africa, Jonathan was then tasked with continuing the growth of the Asian business, whilst establishing and consolidating leading positions in China and India. He later oversaw the acquisition and subsequent integration of SABMiller’s Colombian business and transformation programme in Latin America. Jonathan served the company as an Executive Director on many Boards across multiple jurisdictions and as Chief Financial Officer for the Latin American and Asian regions.

Leading operational and regional teams across Africa, Asia, Central & South America, North America and Europe, Jonathan has extensive international and emerging market experience and played a prominent role in building SABMiller plc into one of the world’s largest and most successful beverage companies.

Stephen Glancey, Group Chief Executive Officer, commented: “We are pleased to announce Jonathan’s appointment as Interim Group Chief Financial Officer. Jonathan brings broad, deep sector expertise and provides continuity to our finance function. His experience and track record will enable him to immediately contribute to the capital allocation decision making process and our strategic direction.”

The process to recruit a permanent Group Chief Financial Officer is ongoing and a further announcement will be made as appropriate.

-ENDS-

About C&C Group plc

C&C Group plc is a premium drinks company which owns, manufactures, markets and distributes branded beer, cider, wine, soft drinks and bottled water. C&C Group brands include: Bulmers the leading Irish cider brand; Tennent’s, the leading Scottish beer brand; Magners the premium international cider brand; Tipperary Water; Finches soft drinks, as well as a range of niche, premium and craft ciders and beers. C&C Group also owns and manufactures Woodchuck, a leading craft cider brand in the United States and manufactures and distributes a number of 3rd party international beer brands in Scotland and Ireland. C&C is also a leading drinks wholesaler in Scotland and Ireland, where it operates under the Tennent's and C&C Gleeson brands respectively. C&C Group is headquartered in Dublin with manufacturing operations in Co. Tipperary, Ireland; Glasgow, Scotland; and Vermont, USA. C&C Group plc is listed on the Irish and London Stock Exchanges.

Contacts

C&C Group plc

Stephen Glancey, Chief Executive

Joe Thompson, Investor Relations

Tel: + 44 7980 844 580

Investors, Analysts & Irish Media

Mark Kenny/Jonathan Neilan

FTI Consulting

Tel: +353 1 765 0886

Email: CandCGroup@fticonsulting.com

UK & International Media

Tim Robertson

Novella Communications

Tel: +44 203 151 7008

Email: TimR@novella-comms.com

View source version on businesswire.com: http://www.businesswire.com/news/home/20170731005908/en/

Copyright Business Wire 2017

Date   Source Headline
4th Jan 202412:45 pmRNSTotal Voting Rights
18th Dec 20233:30 pmRNSDirector/PDMR Shareholding
12th Dec 20231:05 pmRNSHolding(s) in Company
6th Dec 20233:30 pmRNSDirectorate Change
5th Dec 20232:10 pmRNSBlock listing Interim Review
4th Dec 202311:15 amRNSTotal Voting Rights and Capital
16th Nov 20236:00 pmRNSDirector/PDMR Shareholding
2nd Nov 20232:56 pmRNSHolding(s) in Company
2nd Nov 202312:44 pmRNSDirector/PDMR Shareholding
31st Oct 20233:00 pmRNSTotal Voting Rights
30th Oct 20233:45 pmRNSDirector/PDMR Shareholding
26th Oct 20237:00 amBUSHalf-year Report
16th Oct 20235:16 pmRNSDirector/PDMR Shareholding
6th Oct 202312:30 pmRNSHolding(s) in Company
27th Sep 20233:56 pmRNSHolding(s) in Company
19th Sep 20237:00 amBUSStatement re FY2024 H1 pre-close Trading Statement
15th Sep 20232:10 pmRNSDirector/PDMR Shareholding
31st Aug 20237:00 amRNSDirectorate Changes
18th Aug 20239:35 amRNSDirector Declaration
16th Aug 20234:15 pmRNSDirector/PDMR Shareholding
20th Jul 20239:00 amRNSDirector Declaration
17th Jul 20233:15 pmRNSDirector/PDMR Shareholding
13th Jul 20231:00 pmRNSResult of AGM
13th Jul 20237:00 amBUSAGM Statement
6th Jul 20234:00 pmRNSHolding(s) in Company
3rd Jul 20235:45 pmRNSHolding(s) in Company
26th Jun 202312:06 pmRNSHolding(s) in Company
16th Jun 20232:00 pmRNSDirector/PDMR Shareholding
14th Jun 20236:05 pmRNSDirector/PDMR Shareholding
14th Jun 20238:30 amRNSAnnual Report & Notice of AGM
13th Jun 20234:30 pmRNSHolding(s) in Company
1st Jun 20237:00 amRNSBlock listing Interim Review
30th May 20237:00 amRNSHolding(s) in Company
26th May 202312:15 pmRNSDirector/PDMR Shareholding
24th May 20231:45 pmRNSDirector/PDMR Shareholding
24th May 202312:00 pmRNSDirector/PDMR Shareholding
24th May 20237:00 amBUSFinal Results
19th May 20237:00 amBUSStatement re Trading Update & Directorate Changes
16th May 20232:00 pmRNSDirector/PDMR Shareholding
4th May 20231:30 pmRNSHolding(s) in Company
17th Apr 20233:45 pmRNSDirector/PDMR Shareholding
23rd Mar 20237:00 amBUSPre-close Trading Statement
16th Mar 20233:15 pmRNSDirector/PDMR Shareholding
15th Mar 20232:00 pmRNSHolding(s) in Company
23rd Feb 202311:00 amRNSHolding(s) in Company
15th Feb 20234:15 pmRNSDirector/PDMR Shareholding
10th Feb 20232:19 pmBUSStatement re Directorate Changes and Board Committee Update
26th Jan 20233:45 pmRNSHolding(s) in Company
17th Jan 20232:40 pmRNSDirector/PDMR Shareholding
13th Jan 20237:00 amBUSTrading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.